You just read:

ANAVEX RECEIVES APPROVAL TO COMMENCE PHASE I CLINICAL TRIAL IN ALZHEIMER'S DISEASE

News provided by

Anavex Life Sciences Corp.

Mar 15, 2011, 09:00 ET